Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Glenn Whaley is recorded as CFO at Immunic, Inc. (IMUX). The proxy statement of Immunic, Inc. reports total compensation of $1,171,957 for Glenn Whaley in fiscal 2024, including a base salary of $445,000. Disclosed compensation is on record for 6 fiscal years. Glenn Whaley has spoken on 11 earnings calls across 1 company, most recently for Immunic, Inc. on November 7, 2024.
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
Start not stated–present
Proxy statement
Start not stated–2021-04-27
Last confirmed by a filing; no departure on record
Recorded roles and call appearances connecting this person to public companies.
IMUX
CFO
Other people whose current roles at this company are on record from its filings.
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Immunic, Inc. (IMUX) | CFO | $445,000 | $1,171,957 |
| 2023 | Immunic, Inc. (IMUX) | CFO | $415,000 | $702,206 |
| 2022 | Immunic, Inc. (IMUX) | Chief Financial Officer | $401,700 | $1,476,010 |
| 2021 | Immunic, Inc. (IMUX) | Chief Financial Officer The amounts in the “Option Awards” column reflect the aggregate grant date fair value of stock options granted during the calendar year computed in accordance with the provisions of ASC 718. The assumptions that we used to calculate these amounts are discussed in Note 7 to our financial statements appearing at the end of our Annual Report on Form 10-K for the year ended December 31, 2022. These amounts do not reflect the actual economic value that will be realized by the named executive officer upon the vesting of the stock options, the exercise of the stock options, or the sale of the common stock underlying such stock options. An exchange rate of 1.056 Euro to based on the average exchange rate for 2022 was used to convert payment amounts in euros for the table above for both 2021 and 2022 to make the salaries and bonus more comparable year over year. See also footnotes & below re 2021 amounts. Dr. Vitt received payment of his salary in Euros. Dr. Muehler received payment in both and Euros. For Dr. Muehler, represents a pension allowance. For 2022 and 2021, the amount in the “Salary” column represents combined compensation for service as Executive Chairman and the cash retainer payable for service on the Company’s board of directors. In the 2021 proxy statement, the 2021 salary was converted using a rate of 1.18 and the reported salary and bonus for Daniel Vitt was 446,040 and 175,628. In the 2021 proxy statement, the 2021 salary was converted using a rate of 1.18 and the reported salary and bonus for Andreas Muehler was 398,506 and 122,042, respectively. | $343,333 | $928,331 |
| 2020 | Immunic, Inc. (IMUX) | Chief Financial Officer | $310,833 | $848,288 |
| 2019 | Immunic, Inc. (IMUX) | Principal Financial and Accounting Officer | $24,583 | $98,701 |
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
